NCT00374244View on ClinicalTrials.gov

Efficacy of Pimozide Augmentation for Clozapine Partial Response

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Schizophrenia
Interventions
DRUG

Pimozide

half of the subjects are randomized to the active drug group

DRUG

placebo

half of the subjects are randomized to placebo group

Trial Locations (2)

06508

Connecticut Mental Health Center, New Haven

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Yale University

OTHER

NCT00374244 - Efficacy of Pimozide Augmentation for Clozapine Partial Response | Biotech Hunter | Biotech Hunter